Vanguard Group’s NRX Pharmaceuticals NRXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
452,175
+63,250
| +16% | +$206K | ﹤0.01% | 3634 |
|
|
2025
Q1 | $797K | Buy |
388,925
+148,609
| +62% | +$305K | ﹤0.01% | 3779 |
|
|
2024
Q4 | $529K | Hold |
240,316
| – | – | ﹤0.01% | 3938 |
|
|
2024
Q3 | $406K | Hold |
240,316
| – | – | ﹤0.01% | 4023 |
|
|
2024
Q2 | $586K | Sell |
240,316
-1,199,729
| -83% | -$2.93M | ﹤0.01% | 3947 |
|
|
2024
Q1 | $680K | Sell |
1,440,045
-5,132
| -0.4% | -$2.42K | ﹤0.01% | 3935 |
|
|
2023
Q4 | $665K | Sell |
1,445,177
-5,416
| -0.4% | -$2.49K | ﹤0.01% | 3952 |
|
|
2023
Q3 | $377K | Sell |
1,450,593
-27,560
| -2% | -$7.17K | ﹤0.01% | 4134 |
|
|
2023
Q2 | $715K | Hold |
1,478,153
| – | – | ﹤0.01% | 4004 |
|
|
2023
Q1 | $974K | Buy |
1,478,153
+34,990
| +2% | +$23.1K | ﹤0.01% | 3927 |
|
|
2022
Q4 | $1.6M | Buy |
1,443,163
+2,898
| +0.2% | +$3.22K | ﹤0.01% | 3746 |
|
|
2022
Q3 | $1.07M | Buy |
1,440,265
+345,552
| +32% | +$256K | ﹤0.01% | 3978 |
|
|
2022
Q2 | $657K | Buy |
1,094,713
+19,396
| +2% | +$11.6K | ﹤0.01% | 4215 |
|
|
2022
Q1 | $2.63M | Sell |
1,075,317
-96,916
| -8% | -$237K | ﹤0.01% | 3843 |
|
|
2021
Q4 | $5.6M | Buy |
1,172,233
+172,110
| +17% | +$823K | ﹤0.01% | 3544 |
|
|
2021
Q3 | $9.27M | Buy |
1,000,123
+362,707
| +57% | +$3.36M | ﹤0.01% | 3285 |
|
|
2021
Q2 | $7.41M | Buy |
+637,416
| New | +$7.41M | ﹤0.01% | 3371 |
|